Structural highlights
Function
PSA7_YEAST The proteasome degrades poly-ubiquitinated proteins in the cytoplasm and in the nucleus. It is essential for the regulated turnover of proteins and for the removal of misfolded proteins. The proteasome is a multicatalytic proteinase complex that is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. It has an ATP-dependent proteolytic activity.
Publication Abstract from PubMed
The proteasome represents a validated drug target for the treatment of cancer, however, new types of inhibitors are required to tackle the development of resistant tumors. Current fluorescence-based screening methods suffer from low sensitivity and are limited to the detection of ligands with conventional binding profiles. In response to these drawbacks, a crystallographic screening procedure for the discovery of agents with a novel mode of action was utilized. The optimized workflow was applied to the screening of a focused set of compounds, resulting in the discovery of a beta1/beta2-specific sulfonamide derivative that noncovalently binds between subunits beta1 and beta2. The binding pocket displays significant differences in size and polarity between the immuno- and constitutive proteasome. The identified ligand thus provides valuable insights for the future structure-based design of subtype-specific proteasome inhibitors.
Identification of a beta1/beta2-Specific Sulfonamide Proteasome Ligand by Crystallographic Screening.,Beck P, Reboud-Ravaux M, Groll M Angew Chem Int Ed Engl. 2015 Aug 4. doi: 10.1002/anie.201505054. PMID:26242779[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Beck P, Reboud-Ravaux M, Groll M. Identification of a beta1/beta2-Specific Sulfonamide Proteasome Ligand by Crystallographic Screening. Angew Chem Int Ed Engl. 2015 Aug 4. doi: 10.1002/anie.201505054. PMID:26242779 doi:http://dx.doi.org/10.1002/anie.201505054
